Corynebacterium CDC group A-4 native valve endocarditis

Eur J Clin Microbiol Infect Dis. 1991 Dec;10(12):1056-7. doi: 10.1007/BF01984928.

Abstract

A patient with endocarditis caused by Corynebacterium CDC Group A-4 is described. This is the first case in the literature of endocarditis caused by this bacteria, and is unique in that the patient was immune competent and the infection occurred on a native valve. This case illustrates that corynebacteria cannot be considered a contaminant and that the exact pathogen should be identified.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Ampicillin / therapeutic use
  • Corynebacterium / isolation & purification*
  • Corynebacterium Infections / drug therapy
  • Corynebacterium Infections / microbiology*
  • Drug Administration Schedule
  • Endocarditis, Bacterial / drug therapy
  • Endocarditis, Bacterial / microbiology*
  • Gentamicins / therapeutic use
  • Heart Valves / microbiology*
  • Humans
  • Injections, Intravenous
  • Male

Substances

  • Gentamicins
  • Ampicillin